EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels.
about
Overview of Antagonists Used for Determining the Mechanisms of Action Employed by Potential Vasodilators with Their Suggested Signaling PathwaysTranslational Significance of Heme Oxygenase in Obesity and Metabolic SyndromeFunctional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity.CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype.Stem cell transplantation upregulates Sirt1 and antioxidant expression, ameliorating fatty liver in type 2 diabetic mice.Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction.ApoA1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b.CYP2J2 overexpression ameliorates hyperlipidemia via increased fatty acid oxidation mediated by the AMPK pathway.Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasispNaKtide inhibits Na/K-ATPase reactive oxygen species amplification and attenuates adipogenesis.Cyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes.Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade.Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1α Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial FunctionHO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activationDownregulation of PGC-1α Prevents the Beneficial Effect of EET-Heme Oxygenase-1 on Mitochondrial Integrity and Associated Metabolic Function in Obese Mice.PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats.Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic DiseasesPGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid.Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis.Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway.Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling.Periparturient lipolysis and oxylipid biosynthesis in bovine adipose tissues.Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance.
P2860
Q26752401-A30A0338-CE72-428C-ABB7-22F25775F04AQ33847244-7E2297CF-D8BE-4E6B-950D-85A6370DAFA2Q34238703-61B9B866-2D36-4BED-A9AC-4BF888C9AA92Q34506020-8275DFCB-2834-4756-A476-B5248502089EQ35197524-BF1BE3CF-6AAD-4764-8F69-EB73AB8E783CQ35670773-CF41B468-6DE3-4D41-820D-65EA932638FDQ35742804-507E22A1-5214-4808-A9BA-093640786A28Q35866740-665F5CAB-189A-4ED8-8234-3C3271BB9EF3Q36045588-D7212FBB-D51F-44D4-8E88-7CAC55F1030FQ36074375-188543A0-E2CC-41D3-8D8C-BA5335C2333DQ36284868-EA3E3009-27AE-497F-A507-B838946974FBQ36744134-EAFF82A3-FDD8-4A5D-877B-F5564CC903BBQ36997916-764B421E-CD09-4493-B57B-317F53176A39Q37081125-22D0EEEE-9ED7-4926-906A-E9C6AFC58E80Q37166479-7610E172-4A59-4CDF-9179-E8A07E5AFAE2Q37549613-155233EE-6F97-49F9-AFD7-96481407280FQ37631653-A7621547-0BC8-4FC0-90CE-91886E991F74Q37653706-3D8230D5-813B-44B4-9C70-1E185B45015CQ38763928-1BD571D3-6916-4207-98E4-F5CEE983A639Q39600000-0E4FF529-AE33-42FD-ABD1-BF751F32C449Q41172019-D56289AC-88D9-4111-BF42-694AD7293219Q41362375-86F37780-B939-4008-8920-5F81952CE28FQ42711742-FE309814-781F-40C7-8730-4F660DDACF5CQ46028902-4118BEB5-2CF0-4149-9AEA-679931E34B9DQ47165923-25918951-ED6A-49FE-ABEE-099322D34756Q50109203-CF273266-33D7-4D44-8EA1-C6BC3E16F2A2
P2860
EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
EET agonist prevents adiposity ...... nd an increase in HO-1 levels.
@en
EET agonist prevents adiposity ...... nd an increase in HO-1 levels.
@nl
type
label
EET agonist prevents adiposity ...... nd an increase in HO-1 levels.
@en
EET agonist prevents adiposity ...... nd an increase in HO-1 levels.
@nl
prefLabel
EET agonist prevents adiposity ...... nd an increase in HO-1 levels.
@en
EET agonist prevents adiposity ...... nd an increase in HO-1 levels.
@nl
P2093
P2860
P1476
EET agonist prevents adiposity ...... nd an increase in HO-1 levels.
@en
P2093
Kazuyoshi Inoue
Komal Sodhi
Michal L Schwartzman
Nader G Abraham
Nitin Puri
P2860
P304
P356
10.1016/J.PROSTAGLANDINS.2011.12.004
P577
2011-12-24T00:00:00Z